Date:
May 2, 2022
Issue #:
1649
Summary:
The FDA has approved an over-the-counter (OTC)
liquid-filled capsule formulation of aspirin (Vazalore –
PLx Pharma). The manufacturer has been heavily
promoting Vazalore with claims of fast, predictable
absorption and antiplatelet activity and improved
gastrointestinal safety compared to existing OTC
aspirin formulations.
liquid-filled capsule formulation of aspirin (Vazalore –
PLx Pharma). The manufacturer has been heavily
promoting Vazalore with claims of fast, predictable
absorption and antiplatelet activity and improved
gastrointestinal safety compared to existing OTC
aspirin formulations.
